Compass Therapeutics Inc. (CMPX)
NASDAQ: CMPX
· Real-Time Price · USD
3.37
0.00 (0.00%)
At close: Sep 04, 2025, 3:59 PM
3.44
2.08%
After-hours: Sep 04, 2025, 06:14 PM EDT
0.00% (1D)
Bid | 3.28 |
Market Cap | 466.01M |
Revenue (ttm) | n/a |
Net Income (ttm) | -62.03M |
EPS (ttm) | -0.45 |
PE Ratio (ttm) | -7.49 |
Forward PE | -5.91 |
Analyst | Buy |
Ask | 3.46 |
Volume | 386,165 |
Avg. Volume (20D) | 1,042,332 |
Open | 3.39 |
Previous Close | 3.37 |
Day's Range | 3.29 - 3.45 |
52-Week Range | 1.27 - 4.08 |
Beta | 1.30 |
About CMPX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CMPX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CMPX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-5.09%
Compass Therapeutics shares are trading lower afte...
Unlock content with
Pro Subscription
5 months ago
+17.89%
Compass Therapeutics shares are trading higher after the company announced updates and top-line data for COMPANION-002.

3 weeks ago · seekingalpha.com
Compass Therapeutics: Finding Their Way With More Positive Updates In BTCCompass Therapeutics' pipeline shows promise, especially with tovecimig's positive phase 2 results in biliary tract cancers and upcoming basket study plans. CTX-8371's early signals in NSCLC and TNBC ...

2 months ago · https://www.defenseworld.net
Squarepoint Ops LLC Acquires New Holdings in Compass Therapeutics, Inc. (NASDAQ:CMPX)Squarepoint Ops LLC acquired a new stake in Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and...